| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| egfr nsclc treatment | 1.86 | 0.8 | 3262 | 33 | 20 |
| egfr | 1.48 | 0.9 | 6890 | 84 | 4 |
| nsclc | 0.35 | 1 | 2307 | 76 | 5 |
| treatment | 0.3 | 0.3 | 6117 | 43 | 9 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| egfr nsclc treatment | 0.08 | 0.1 | 2174 | 64 |
| nsclc egfr mutation treatment | 0.98 | 1 | 9619 | 83 |
| egfr positive nsclc treatment | 1.52 | 0.9 | 3702 | 59 |
| first line egfr nsclc treatment | 1.63 | 0.2 | 2768 | 76 |
| nsclc treatment after egfr tki failure | 0.68 | 0.3 | 4582 | 3 |
| nsclc with egfr mutation | 0.76 | 0.5 | 8427 | 36 |
| egfr mutation positive nsclc | 1.06 | 0.8 | 1594 | 45 |
| percentage of egfr mutation in nsclc | 1.54 | 0.4 | 8819 | 35 |
| egfr mutation nsclc prevalence | 0.47 | 0.5 | 9750 | 64 |
| incidence of egfr mutations in nsclc | 1.13 | 0.2 | 6816 | 98 |
| radiomic detection of egfr mutations in nsclc | 1.93 | 0.2 | 7705 | 79 |
| uncommon egfr mutations nsclc | 1.49 | 0.8 | 1129 | 6 |
| prevalence of egfr mutations in nsclc | 0.97 | 0.3 | 3172 | 85 |
| nsclc gene mutation treatment | 1 | 0.8 | 6395 | 86 |
| egfrm+ nsclc | 1.7 | 0.2 | 4976 | 44 |
| nsclc egfr test sample | 1.85 | 0.1 | 7768 | 77 |
| lung cancer egfr mutation treatment | 1.16 | 0.2 | 4529 | 16 |
| egfr wild type nsclc | 0.69 | 0.3 | 7221 | 51 |
| egfr gene mutation lung cancer treatment | 1.49 | 0.6 | 8545 | 46 |
| new treatment for nsclc | 1.27 | 0.8 | 3061 | 56 |
| egfr exon 18 mutation treatment | 0.49 | 0.1 | 2376 | 42 |
| egfr exon 19 mutation treatment | 1 | 0.3 | 6276 | 10 |
| ncl-l-egfr | 1.3 | 0.5 | 2038 | 21 |
